References
- MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
- UchmanowiczIJankowska-PolanskaBMotowidloUUchmanowiczBChabowskiMAssessment of illness acceptance by patients with COPD and the prevalence of depression and anxiety in COPDInt J Chron Obstruct Pulmon Dis20161196397027274217
- DingBDiBonaventuraMKarlssonNBergströmGHolmgrenUA cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness SurveyInt J Chron Obstruct Pulmon Dis20171252953928223793
- HananiaNAMüllerovaHLocantoreNWEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigatorsDeterminants of depression in the ECLIPSE chronic obstructive pulmonary disease cohortAm J Respir Crit Care Med2011183560461120889909
- MikkelsenRLMiddelboeTPisingerCStageKBAnxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A reviewNord J Psychiatry2004581657014985157
- NgTNitiMTanWCaoZOngKEngPDepressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of lifeArch Intern Med20071671606717210879
- OuelletteDRLKRecognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPDInt J Chron Obstruct Pulmon Dis20171263965028243081
- HynninenMJFactors affecting health status in COPD patients with co-morbid anxiety or depressionInt J Chron Obstruct Pulmon Dis20072332332818229570
- BoströmPWuJJedrychowskiMPA PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature2012481738246346822237023
- HandschinCSpiegelmanBMThe role of exercise and PGC1α in inflammation and chronic diseaseNature2008454720346346918650917
- LeckerSHZavinACaoPExpression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failureCirc Heart Fail20125681281823001918
- WrannCDWhiteJPSalogiannnisJExercise induces hippocampal BDNF through a PGC-1a/FNDC5 pathwayCell Metab201318564965924120943
- SteinerJLMurphyEAMcClellanJLCarmichaelMDDavisJMExercise training increases mitochondrial biogenesis in the brainJ Appl Physiol (1985)201111141066107121817111
- ZsugaJBiroKPappCTajtiGGesztelyiRThe “proactive” model of learning: Integrative framework for model-free and model-based reinforcement learning utilizing the associative learning-based proactive brain conceptBehav Neurosci2016130161826795580
- ZsugaJBiroKTajtiG‘Proactive’ use of cue-context congruence for building reinforcement learning’s reward functionBMC Neurosci20161717027793098
- KristófEDoan-XuanQBaiPBacsoZFésüsLLaser-scanning cytometry can quantify human adipocyte browning and proves effectiveness of irisinSci Rep201551254026212086
- PhillipsCBaktirMASrivatsanMSalehiANeuroprotective effects of physical activity on the brain: a closer look at trophic factor signalingFront Cell Neurosci2014817024999318
- ZsugaJTajtiGPappCJuhaszBGesztelyiRFNDC5/irisin, a molecular target for boosting reward-related learning and motivationMed Hypotheses201690232827063080
- YanQSFengMJYanSEDifferent expression of brain-derived neurotrophic factor in the nucleus accumbens of alcohol-preferring (P) and-nonpreferring (NP) ratsBrain Res20051035221521815722062
- JeanblancJHeDYMcGoughNNThe dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumptionJ Neurosci20062651457146416452669
- GuillinOGriffonNBezardEBrain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson’s diseaseEur J Pharmacol20034801–3899514623353
- MaiaTVReinforcement learning, conditioning, and the brain: Successes and challengesCogn Affect Behav Neurosci20099434336419897789
- PulcuETrotterPDThomasEJTemporal discounting in major depressive disorderPsychol Med20144491825183424176142
- HuysQJPizzagalliDABogdanRDayanPMapping anhedonia onto reinforcement learning: a behavioural meta-analysisBiol Mood Anxiety Disord2013311223782813
- NestlerEJCarlezonWAThe mesolimbic dopamine reward circuit in depressionBiol Psychiatry200659121151115916566899
- Von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE InitiativeThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studiesInt J Surg20141241495149925046131
- TajtiGGesztelyiRPakKPositive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammationInt J Chron Obstruct Pulmon Dis20171287388428352168
- KollégiumTSAz Egészségügyi Minisztérium szakmai irányelve a krónikus obstruktiv légúti betegség (chronic obstructive pulmonary disease – COPD) diagnosztikájáról és kezeléséről (1. módosított változat) [Clinical practice guidelines of the Ministry of Health on diagnosis and management of chronic obstructive pulmonary disease (COPD) (first modified version)]Magyar Közlöny20092136613692 Hungarian
- RabeKFHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
- CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
- SwanneyMPRuppelGEnrightPLUsing the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstructionThorax200863121046105118786983
- NathellLNathellMMalmbergPLarssonKCOPD diagnosis related to different guidelines and spirometry techniquesRespir Res200788918053200
- MeguroMBarleyEASpencerSJonesPWDevelopment and validation of an improved, COPD-specific version of the St. George Respiratory QuestionnaireChest2007132245646317646240
- MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
- WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
- ZsugaJTörökJMagyarMTDimethylarginines at the crossroad of insulin resistance and atherosclerosisMetabolism200756339439917292729
- JonesPWQuirkFBaveystockCThe St George’s respiratory questionnaireRespir Med199185Suppl B2531 discussion 33–371759018
- JonesPWSt. George’s respiratory questionnaire: MCIDCOPD200521757917136966
- FerrerMVillasanteCAlonsoJInterpretation of quality of life scores from the St George’s Respiratory QuestionnaireEur Respir J200219340541311936515
- LambertAAPutchaNDrummondMBCOPD Gene InvestigatorsObesity is associated with increased morbidity in moderate to severe COPDChest20171511687727568229
- HoSCHsuMFKuoHPThe relationship between anthropometric indicators and walking distance in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101857186226392760
- TanniSEZamunerATCoelhoLSValeSAGodoyIPaivaSAAre metabolic syndrome and its components associated with 5-year mortality in chronic obstructive pulmonary disease patients?Metab Syndr Relat Disord2015131525425353094
- CatalfoGCreaLLo CastroTDepression, body mass index, and chronic obstructive pulmonary disease – a holistic approachInt J Chron Obstruct Pulmon Dis20161123924926929612
- VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
- DiazAAPetersenHMeekPSoodACelliBTesfaigziYDifferences in health-related quality of life between new Mexican hispanic and non-hispanic white smokersChest2016150486987627321735
- WellingJBHartmanJETen HackenNHKloosterKSlebosDJThe minimal important difference for the St George’s Respiratory Questionnaire in patients with severe COPDEur Respir J20154661598160426493797
- JonesPWAndersonJACalverleyPMTORCH investigatorsHealth status in the TORCH study of COPD: treatment efficacy and other determinants of changeRespir Res2011127121627828
- DumanRSHeningerGRNestlerEJA molecular and cellular theory of depressionArch Gen Psychiatry19975475976069236543
- JeonSWKimYKMolecular neurobiology and promising new treatment in depressionInt J Mol Sci201617338126999106
- IharaKYoshidaHJonesPBSerum BDNF levels before and after the development of mood disorders: a case-control study in a population cohortTransl Psychiatry20166e78227070410
- BrunoniARLopesMFregniFA systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depressionInt J Neuropsychopharmacol20081181169118018752720
- KheirouriSNoorazarSGAlizadehMDana-AlamdariLElevated brain-derived neurotrophic factor correlates negatively with severity and duration of major depressive episodesCogn Behav Neurol2016291243127008247
- GrovesJOIs it time to reassess the BDNF hypothesis of depression?Mol Psychiatry200712121079108817700574
- IjiriNKanazawaHAsaiKWatanabeTHirataKIrisin, a newly discovered myokine, is a novel biomarker associated with physical activity in patients with chronic obstructive pulmonary diseaseRespirology201520461261725800067
- KureyaYKanazawaHIjiriNDown-regulation of soluble α-Klotho is associated with reduction in serum irisin levels in chronic obstructive pulmonary diseaseLung2016194334535127140192
- StollPWuertembergerUBratkeKZinglerCVirchowJCLommatzschMStage-dependent association of BDNF and TGF-β 1 with lung function in stable COPDRespir Res20121311623245944
- JacobyASMunkholmKVinbergMPedersenBKKessingLVCytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder – Results from a prospective studyJ Affect Disord201619716717426994434
- FaillaMDConleyYPWagnerAKBrain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: interrelationships between genetics and acute systemic and central nervous system BDNF profilesNeurorehabil Neural Repair2016301839325979196
- ChuangMLLinIFLeeCYClinical assessment tests in evaluating patients with chronic obstructive pulmonary disease: a cross-sectional studyMedicine (Baltimore)20169547e547127893695
- JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitationAm Rev Respir Dis19921456132113271595997
- EffingTWLenferinkABuckmanJDevelopment of a self-treatment approach for patients with COPD and comorbidities: an ongoing learning processJ Thorac Dis20146111597160525478200